These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15105807)

  • 1. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature.
    Freeman A; Geddes N; Munson P; Joseph J; Ramani P; Sandison A; Fisher C; Parkinson MC
    Mod Pathol; 2004 Jul; 17(7):765-71. PubMed ID: 15105807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
    Zhang YH; Zhang XR; Yu J; Li HL
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.
    Iczkowski KA; Shanks JH; Gadaleanu V; Cheng L; Jones EC; Neumann R; Nascimento AG; Bostwick DG
    Mod Pathol; 2001 Oct; 14(10):1043-51. PubMed ID: 11598176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X; Montgomery E; Sun B
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.
    Choi E; Williamson SR; Montironi R; Zhang S; Wang M; Eble JN; Grignon DJ; Lopez-Beltran A; Idrees MT; Baldridge LA; Scarpelli M; Jones CL; Wang L; MacLennan GT; Osunkoya AO; Cheng L
    Histopathology; 2015 Jul; 67(1):20-38. PubMed ID: 25406945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract.
    Hirsch MS; Dal Cin P; Fletcher CD
    Histopathology; 2006 Apr; 48(5):569-78. PubMed ID: 16623783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
    Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
    Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of anaplastic lymphoma kinase-1 expression in inflammatory myofibroblastic tumors of the central nervous system: does it signify a different nosologic entity from its systemic counterpart?
    Govindan A; Mahadevan A; Chakraborti S; Furtado S; Krishna S
    Indian J Pathol Microbiol; 2014; 57(2):178-82. PubMed ID: 24943745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
    Schöffski P; Sufliarsky J; Gelderblom H; Blay JY; Strauss SJ; Stacchiotti S; Rutkowski P; Lindner LH; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Nzokirantevye A; Collette S; Wozniak A
    Lancet Respir Med; 2018 Jun; 6(6):431-441. PubMed ID: 29669701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.
    Sukov WR; Cheville JC; Carlson AW; Shearer BM; Piatigorsky EJ; Grogg KL; Sebo TJ; Sinnwell JP; Ketterling RP
    Mod Pathol; 2007 May; 20(5):592-603. PubMed ID: 17396140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining.
    Rao RN; Ranjan P; Singla N; Pandey R
    Urol Ann; 2012 May; 4(2):115-8. PubMed ID: 22629012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-lineage interrogation of the performance characteristics of a split-signal fluorescence in situ hybridization probe for anaplastic lymphoma kinase gene rearrangements: a study of 101 cases characterized by immunohistomorphology on fixed archival tissue.
    Tan LH; Do E; Tan SY; Chong SM; Koay ES
    Mol Diagn; 2004; 8(4):213-29. PubMed ID: 15887977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of inflammatory myofibroblastic tumor of the urinary bladder finally diagnosed by anaplastic lymphoma kinase (ALK) immunostaining].
    Takeshita H; Kawakami S; Okubo Y; Yamamoto S; Yonese J; Fukui I; Kono A; Kurata M; Inoshita N; Ishikawa Y
    Hinyokika Kiyo; 2006 May; 52(5):375-8. PubMed ID: 16758729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular inflammatory myofibroblastic tumor with ALK overexpression.
    O'Malley DP; Poulos C; Czader M; Sanger WG; Orazi A
    Arch Pathol Lab Med; 2004 Jan; 128(1):e5-7. PubMed ID: 14692830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study.
    Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA
    Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.
    Yamamoto H; Oda Y; Saito T; Sakamoto A; Miyajima K; Tamiya S; Tsuneyoshi M
    Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammatory myofibroblastic tumors of the urinary bladder: a clinicopathological study of ten cases].
    Zhang HZ; Wang SY; Dong L; Yang XQ; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1024-1028. PubMed ID: 34496493
    [No Abstract]   [Full Text] [Related]  

  • 20. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder.
    Bertz S; Stöhr R; Gaisa NT; Wullich B; Hartmann A; Agaimy A
    Histopathology; 2020 Dec; 77(6):949-962. PubMed ID: 32645760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.